Cargando…
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
In light of the current outbreak of Ebola virus disease, there is an urgent need to develop effective therapeutics to treat Ebola infection, and drug repurposing screening is a potentially rapid approach for identifying such therapeutics. We developed a biosafety level 2 (BSL-2) 1536-well plate assa...
Autores principales: | Kouznetsova, Jennifer, Sun, Wei, Martínez-Romero, Carles, Tawa, Gregory, Shinn, Paul, Chen, Catherine Z, Schimmer, Aaron, Sanderson, Philip, McKew, John C, Zheng, Wei, García-Sastre, Adolfo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317638/ https://www.ncbi.nlm.nih.gov/pubmed/26038505 http://dx.doi.org/10.1038/emi.2014.88 |
Ejemplares similares
-
Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection
por: Veljkovic, Veljko, et al.
Publicado: (2015) -
Potential COVID-19 papain-like protease PL(pro) inhibitors: repurposing FDA-approved drugs
por: Kouznetsova, Valentina L., et al.
Publicado: (2020) -
Rapid Identification of Antifungal Compounds against Exserohilum rostratum Using High Throughput Drug Repurposing Screens
por: Sun, Wei, et al.
Publicado: (2013) -
Correction: Rapid Identification of Antifungal Compounds against Exserohilum rostratum Using High Throughput Drug Repurposing Screens
por: Sun, Wei, et al.
Publicado: (2013) -
Correction: Rapid Identification of Antifungal Compounds against Exserohilum rostratum Using High Throughput Drug Repurposing Screens
por: Sun, Wei, et al.
Publicado: (2013)